Vertex reports Q3 earnings on Nov. 2 with cystic fibrosis revenue still dominant, but a $500 million target for two newer therapies will tell investors whether the company can actually launch at scale beyond…
Apple reports fiscal fourth-quarter results on Nov. 2 carrying a $5 trillion valuation, a memory cost squeeze Tim Cook called a once-in-a-century event, and a pattern of falling on earnings beats. Three forces will…
Regeneron reports earnings on Oct. 30, and a quiet accounting change tied to its Sanofi partnership may finally reveal what Dupixent is actually worth to the bottom line. Most of Wall Street has barely…
Colgate-Palmolive heads into earnings with a 21% rally behind it, a demanding valuation, and a North American business that has shrunk for four straight quarters. Something has to give, and Friday's report may reveal…
Dominion just posted six straight earnings beats while its data center pipeline swells past 53 gigawatts, but Virginia regulators are threatening a freeze that could gut the base-rate growth powering the whole story.
Exelon reports earnings before the open on Oct. 30, and buried inside the call is a transmission pipeline question that could shift how Wall Street prices this utility for years to come.
Cameco has missed earnings estimates five quarters straight while trading at a valuation that assumes near-perfection, and its October 30 report arrives just as mine shutdowns and processing problems cloud what the Street expects…
Rivian just posted record quarterly deliveries, yet shares have cratered nearly 40% this year and the cash keeps flowing out. The October 29 earnings report will reveal whether surging volume is finally bending the…
AXT shares have shed more than a quarter of their value in a single month, yet analysts expect the company to flip from loss to profit when it reports on Oct. 29. Three specific…
Harley-Davidson shares have surged nearly 45% this year on the back of a turnaround story, but two straight earnings-day selloffs raise a pointed question about what the market actually wants to see when the…
Exxon's refining business delivered a historic quarter, but crude prices moved sharply against it heading into the Oct. 30 earnings call. Find out which force came out on top and what it means for…
AbbVie heads into its October 30 earnings report riding a 28% rally and fresh FDA approvals, but options traders are bracing for a 5% swing in either direction and the stock has a recent…
Chevron has beaten consensus seven quarters in a row and analysts are forecasting triple-digit earnings growth, yet the last blowout quarter sent the stock down. Find out what will actually move shares when results…
AstraZeneca heads into its October 30 earnings call with oncology surging and its cardiology franchise under pressure, leaving investors to wonder whether new drug launches can absorb the losses fast enough to justify a…
BP heads into its Oct. 30 earnings report carrying billions in potential write-downs while simultaneously boasting record refining margins and a stock on a 13% tear. Which force wins, and what it means for…
General Dynamics heads into its Oct. 30 earnings report sitting on a record backlog and six straight beats, yet the stock has barely budged all year. Find out what new CEO Danny Deep needs…
Align Technology has beaten earnings estimates four straight quarters and watched its stock fall each time, so something bigger needs to change when Q3 results land October 28. Whether surging international aligner demand can…
Antero Midstream tripled its buyback pace in Q3 and slashed hundreds of millions in high-cost debt, but two straight EPS misses mean Wednesday's report after the bell must prove whether that financial cleanup finally…
Etsy sold Depop, slashed its workforce, and authorized a $2 billion buyback, but the real question heading into October 28 earnings is whether marketplace momentum alone can justify the transformation before tougher comparisons arrive.
Vista Energy reports on October 28 with Brent oil briefly topping $130 and a full quarter of newly acquired Vaca Muerta assets on the books. Whether that windfall survived peso costs and geopolitical chaos…
